Innoviva, Inc. — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2014-06-02

Reporting Person: Mammen Mathai (SVP, Research & Early Clin Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-02	Common Stock	A	50000	—	Acquired	287936	Direct
2014-06-02	Common Stock	A	21000	—	Acquired	308936	Direct

Footnotes

F1: On February 11, 2011, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a six-year timeframe from 2011 through December 31, 2016 and continued employment. On June 2, 2014, the performance conditions applicable to 21,000 shares were deemed achieved and such shares will vest on June 2, 2015, subject to the reporting person's continued employment through such date.